● Recruiting

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Condition: EPP · XLP · Sponsor: Tanabe Pharma America, Inc.

PhasePhase 3

Planned participants301

Who can joinAll sexes, 12 Years to 75 Years

Healthy volunteersNo

About this study

To evaluate the long-term safety and tolerability of oral dersimelagon.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trials Information Desk, To prevent mis-communication, · please e-mail · information.US@mb.tanabe-pharma.com

Always discuss trial participation with your own doctor first.

Locations (51)

Marvel Clinical Research, LLC	Huntington Beach, California, United States	Recruiting
University of California at San Francisco - CSF Porphyria Center	San Francisco, California, United States	Not Yet Recruiting
University Of Miami School Of Medicine, Center For Liver Diseases	Miami, Florida, United States	Not Yet Recruiting
Massachusetts General Hospital	Boston, Massachusetts, United States	Not Yet Recruiting
MetroBoston Clinical Partners, LLC	Brighton, Massachusetts, United States	Recruiting
Henry Ford Health System	Detroit, Michigan, United States	Not Yet Recruiting
Kansas City Research Institute	Kansas City, Missouri, United States	Recruiting
Icahn School of Medicine at Mount Sinai (ISSMS)-The Mount Sinai Hospital (MSH)	New York, New York, United States	Recruiting
Wake Forest University Baptist Health	Winston-Salem, North Carolina, United States	Recruiting
Cleveland Clinic - Taussig Cancer Institute	Cleveland, Ohio, United States	Not Yet Recruiting
Remington-Davis Clinical Research	Columbus, Ohio, United States	Recruiting
Thomas Jefferson University	Philadelphia, Pennsylvania, United States	Recruiting

+ 39 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05005975